$NLS Pharmaceutics (NLSP.US)$ Pharmaceutics (NLSP) said Frid...
$NLS Pharmaceutics(NLSP.US$ Pharmaceutics (NLSP) said Friday it has signed an exclusive option agreement under which it may acquire global development and commercialization rights to Aexon Labs' assets for the potential treatment of narcolepsy and other neuro-degenerative disorders.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment